Phase II, Randomized Double-blind Study of Efficacy and Safety of Two Dose Levels of LDE225 in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
Phase II, Randomized Double-blind Study of Efficacy and Safety of Two Dose Levels of LDE225 in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
This study assessed the efficacy and safety of oral treatment with two dose levels of LDE225 in patients with locally advanced or metastatic BCC.
Inclusion Criteria:
Exclusion Criteria:
Tampa, Florida 33612, United States
Chicago, Illinois 60611, United States
St Louis, Missouri 63110, United States
Las Vegas, Nevada 89109, United States
Hershey, Pennsylvania 17033-085, United States
Dallas, Texas 75246, United States
Salt Lake City, Utah 84103, United States